Clinical Trial Update: S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial (S0511) evaluating goserelin in combination with anastrozole for men with recurrent or metastatic breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Zoladex (goserelin)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer | Phase 2 | Status: WITHDRAWN